Wael R Abd-Elgaliel1, Ching-Hsuan Tung. 1. Department of Radiology, The Methodist Hospital Research Institute, Weill Cornell Medical College, Houston, TX, USA.
Abstract
BACKGROUND: Aspartic proteases Cathepsin (Cath) E and D are two different proteases, but they share many common characteristics, including molecular weight, catalytic mechanism, substrate preferences, proteolytic conditions and inhibition susceptibility. To define the biological roles of these proteases, it is necessary to elucidate their substrate specificity. In the present study, we report a new peptide-substrate that is only sensitive to Cath E but not Cath D. METHODS: Substrate e, Mca-Ala-Gly-Phe-Ser-Leu-Pro-Ala-Lys(Dnp)-DArg-CONH₂, designed in such a way that due to the close proximity of a Mca-donor and a Dnp-acceptor, near complete intramolecular quenching effect was achieved in its intact state. After the proteolytic cleavage of the hydrophobic motif of peptide substrate, both Mca and Dnp would be further apart, resulting in bright fluorescence. RESULTS: Substrate e showed a 265 fold difference in the net fluorescence signals between Cath E and D. This Cath E selectivity was established by having -Leu**Pro- residues at the scissile peptide bond. The confined cleavage site of substrate e was confirmed by LC-MS. The catalytic efficiency (K(cat)/K(M)) of Cath E for substrate e was 16.7 μM⁻¹S⁻¹. No measurable catalytic efficiency was observed using Cath D and no detectable fluorescent changes when incubated with Cath S and Cath B. CONCLUSIONS: This study demonstrated the promise of using the developed fluorogenic substrate e as a selective probe for Cath E proteolytic activity measurement. GENERAL SIGNIFICANCE: This study forms the foundation of Cath E specific inhibitor development in further studies.
BACKGROUND: Aspartic proteases Cathepsin (Cath) E and D are two different proteases, but they share many common characteristics, including molecular weight, catalytic mechanism, substrate preferences, proteolytic conditions and inhibition susceptibility. To define the biological roles of these proteases, it is necessary to elucidate their substrate specificity. In the present study, we report a new peptide-substrate that is only sensitive to Cath E but not Cath D. METHODS: Substrate e, Mca-Ala-Gly-Phe-Ser-Leu-Pro-Ala-Lys(Dnp)-DArg-CONH₂, designed in such a way that due to the close proximity of a Mca-donor and a Dnp-acceptor, near complete intramolecular quenching effect was achieved in its intact state. After the proteolytic cleavage of the hydrophobic motif of peptide substrate, both Mca and Dnp would be further apart, resulting in bright fluorescence. RESULTS: Substrate e showed a 265 fold difference in the net fluorescence signals between Cath E and D. This Cath E selectivity was established by having -Leu**Pro- residues at the scissile peptide bond. The confined cleavage site of substrate e was confirmed by LC-MS. The catalytic efficiency (K(cat)/K(M)) of Cath E for substrate e was 16.7 μM⁻¹S⁻¹. No measurable catalytic efficiency was observed using Cath D and no detectable fluorescent changes when incubated with Cath S and Cath B. CONCLUSIONS: This study demonstrated the promise of using the developed fluorogenic substrate e as a selective probe for Cath E proteolytic activity measurement. GENERAL SIGNIFICANCE: This study forms the foundation of Cath E specific inhibitor development in further studies.
Authors: K Uno; T Azuma; M Nakajima; K Yasuda; T Hayakumo; H Mukai; T Sakai; K Kawai Journal: J Gastroenterol Hepatol Date: 2000-11 Impact factor: 4.029
Authors: Sam L Ivry; Jeremy M Sharib; Dana A Dominguez; Nilotpal Roy; Stacy E Hatcher; Michele T Yip-Schneider; C Max Schmidt; Randall E Brand; Walter G Park; Matthias Hebrok; Grace E Kim; Anthony J O'Donoghue; Kimberly S Kirkwood; Charles S Craik Journal: Clin Cancer Res Date: 2017-04-19 Impact factor: 12.531
Authors: Edmund J Keliher; Thomas Reiner; Sarah Earley; Jenna Klubnick; Carlos Tassa; Andrew J Lee; Sridhar Ramaswamy; Nabeel Bardeesy; Douglas Hanahan; Ronald A Depinho; Cesar M Castro; Ralph Weissleder Journal: Neoplasia Date: 2013-07 Impact factor: 5.715
Authors: Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate Journal: Pancreatology Date: 2019-09-20 Impact factor: 3.996
Authors: Thiruvengadam Arumugam; Vijaya Ramachandran; Duoli Sun; Zhenghong Peng; Ashutosh Pal; David S Maxwell; William G Bornmann; Craig D Logsdon Journal: Mol Cancer Ther Date: 2013-01-09 Impact factor: 6.261